Follow
Parisa Asgarisabet
Parisa Asgarisabet
Verified email at uth.tmc.edu
Title
Cited by
Cited by
Year
Regional intervention of stroke care to increase thrombolytic therapy for acute ischemic stroke: the Southeast Texas experience
RH Damani, S Anand, P Asgarisabet, C Bissell, S Savitz, JI Suarez
Stroke 49 (8), 2008-2010, 2018
102018
Fungi: friend or foe? A mycobiome evaluation in children with autism and gastrointestinal symptoms
J Alookaran, Y Liu, TA Auchtung, A Tahanan, M Hessabi, P Asgarisabet, ...
Journal of pediatric gastroenterology and nutrition 74 (3), 377-382, 2022
32022
The beneficial effect of providing kidney transplantation information on transplantation status differs between for‐profit and nonprofit dialysis centers
P Asgarisabet, SS Rajan, MJ Lee, RO Morgan, LD Highfield, KF Erickson
Transplant International 34 (12), 2644-2668, 2021
32021
Resistin levels decrease as insulin resistance increases in a Mexican-American cohort
AD Gutierrez, CA Flores, S Naik, MJ Lee, P Asgarisabet, M Resman, ...
Cytokine 148, 155687, 2021
32021
HSR24-172: Comparing Apples to Apples in Uterine Cancer: Racial Disparity and Propensity Score Matching
A Balanean, Y Jeune-Smith, P Asgarisabet, C Craig, H Hays, JL Laney, ...
Journal of the National Comprehensive Cancer Network 22 (2.5), 2024
2024
Characteristics of patients with advanced renal cell carcinoma (aRCC) who received first-line (1L) nivolumab plus cabozantinib (NIVO+ CABO), pembrolizumab plus lenvatinib (PEM+ …
KK Zarrabi, B Miron, X Yin, L Rosenblatt, SB Guttenplan, W John, ...
Cancer Research 84 (6_Supplement), 5095-5095, 2024
2024
RWD95 Comparing Representativeness of Race and Ethnicity in Real-World Evidence, Randomized Clinical Trial, and Surveillance, Epidemiology, and End Results (SEER) Cancer …
A Balanean, D Gentile, M Brown, P Asgarisabet, D Chopra, S Swain, ...
Value in Health 26 (6), S378, 2023
2023
RWD13 Representation of Sex at Birth in Real-World Evidence, Randomized Clinical Trial, and Surveillance, Epidemiology, and End Results (SEER) Cancer Patient Registry Data By …
D Gentile, A Balanean, M Brown, P Asgarisabet, K Savill, D Chopra, ...
Value in Health 26 (6), S362, 2023
2023
RWD18 Age Comparisons across Real-World Evidence Research, Randomized Clinical Trials, and Surveillance, Epidemiology, and End Results (SEER) in Advanced Cancer
TA Schuler, A Balanean, P Asgarisabet, D Gentile, M Brown, KZ Savill, ...
Value in Health 26 (6), S363, 2023
2023
Comparison of diversity across real-world evidence, randomized clinical trial, and Surveillance, Epidemiology, and End Results (SEER) data in patients with metastatic breast …
D Gentile, A Balanean, P Asgarisabet, M Brown, RS Swain, AJ Klink, ...
Journal of Clinical Oncology 41 (16_suppl), e18670-e18670, 2023
2023
Representation of age, race and ethnicity in real-world evidence (RWE), randomized clinical trial (RCT), and Surveillance, Epidemiology, and End Results (SEER) cancer patient …
M Garretson, D Gentile, M Brown, P Asgarisabet, RS Swain, AJ Klink, ...
Journal of Clinical Oncology 41 (16_suppl), e18672-e18672, 2023
2023
Differences in racial and sex at birth representativeness between randomized controlled trial (RCT) and real-world evidence (RWE) or Surveillance, Epidemiology, and End Results …
KMZ Savill, D Gentile, P Asgarisabet, M Brown, D Chopra, WS John, ...
Journal of Clinical Oncology 41 (16_suppl), e18654-e18654, 2023
2023
Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer
KMZ Savill, J Ivanova, P Asgarisabet, A Falkenstein, A Balanean, ...
The oncologist 28 (5), 414-424, 2023
2023
AJPH Peer Reviewers: Thank You for Your Services
B Selzer, M Henry, K Poe, A Ferguson
American Journal of Public Health 112 (12), e4-e21, 2022
2022
Clinical and Demographic Characteristics of Patients with RF plus/ACPA plus RA and First-Line TNF Inhibitor versus Abatacept Treatment Choice in Real-World Clinical Practice
G Lam, H Zheng, E Bland, V Patel, L N'Dri, P Asgarisabet, K Wittstock, ...
ARTHRITIS & RHEUMATOLOGY 74, 2792-2793, 2022
2022
The Use of Dual Therapy vs Triple Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome: A Network Meta-analysis of Randomized Clinical Trials (4957)
A Desai, C Escamilla-Ocanas, P Asgarisabet, R Damani
Neurology 94 (15 Supplement), 2020
2020
Abstract TP94: White Matter Tract Integrity After Vascular Insult: Longitudinal Analysis of Hemorrhagic vs Ischemic Lesions
D Rosenbaum-Halevi, KN Parsha, SD George, SB Boren, CW Sitton, ...
Stroke 51 (Suppl_1), ATP94-ATP94, 2020
2020
Predictors Of Kidney Transplant Receipt And Medicare Costs For Patients
P Asgarisabet
2020
Peace of Mind Program: Impact of the Dissemination and Implementation of an Mammography Adherence Evidence Based Intervention
P Asgarisabet, S Rajan, G Walton, G Ferguson, L Highfield
2019 Annual Research Meeting, 2019
2019
Novel Associations of Adipokines and Atherosclerotic Markers with Rising Levels of Insulin Resistance in a Mexican-American Border Population
AD GUTIERREZ, CA Flores, M Lee, S Laing, P Asgarisabet, M Resman, ...
Diabetes 67 (Supplement_1), 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20